We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

VAXIMM To Announce First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy in Combination with Avelumab

Product News   May 14, 2020

 
VAXIMM To Announce First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy in Combination with Avelumab
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

International Freezer Challenge 2021: Optimizing Your Cold Storage Practices?

Product News

The International Institute for Sustainable Laboratories (I2SL) and MyGreenLab have partnered again to reward the best concept to improve cold storage regarding sustainability: The Freezer Challenge 2021.

READ MORE

$10 Million Grant from Exact Sciences To Support Stand up to Cancer Initiative

Product News

Today Stand Up To Cancer announced a collaborative initiative aimed at improving colorectal cancer screening with a grant provided by Exact sciences.

READ MORE

Nēsos Unveils Wireless Earbud for the Treatment of Rheumatoid Arthritis

Product News

A new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields is being developed by scientists, to regulate immune function.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE